$BKNG
Booking Holdings Inc.

2024 Q2 Form 10-Q Financial Statement

#000107553124000027 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $5.859B $4.415B $3.778B
YoY Change 7.27% 16.86% 40.19%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.051B $1.796B $1.806B
YoY Change -44.07% -0.55% 38.39%
% of Gross Profit
Research & Development $183.0M $187.0M $137.0M
YoY Change 27.08% 36.5% 2.24%
% of Gross Profit
Depreciation & Amortization $142.0M $137.0M $120.0M
YoY Change 17.36% 14.17% 8.11%
% of Gross Profit
Operating Expenses $4.003B $3.624B $3.328B
YoY Change 5.68% 8.89% 32.01%
Operating Profit $1.856B $791.0M $450.0M
YoY Change 10.94% 75.78% 158.62%
Interest Expense $65.00M $219.0M $194.0M
YoY Change -214.04% 12.89% 185.29%
% of Operating Profit 3.5% 27.69% 43.11%
Other Income/Expense, Net $37.00M $122.0M $47.00M
YoY Change 1750.0% 159.57% -104.92%
Pretax Income $1.922B $937.0M $303.0M
YoY Change 18.79% 209.24% -135.69%
Income Tax $401.0M $161.0M $37.00M
% Of Pretax Income 20.86% 17.18% 12.21%
Net Earnings $1.521B $776.0M $266.0M
YoY Change 17.91% 191.73% -138.0%
Net Earnings / Revenue 25.96% 17.58% 7.04%
Basic Earnings Per Share $44.94 $22.69 $7.07
Diluted Earnings Per Share $44.38 $22.37 $7.00
COMMON SHARES
Basic Shares Outstanding 33.93M shares 34.17M shares 37.65M shares
Diluted Shares Outstanding 34.27M shares 34.71M shares 37.98M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.33B $15.99B $14.50B
YoY Change 7.12% 10.29% 37.44%
Cash & Equivalents $16.29B $15.63B $14.14B
Short-Term Investments $37.00M $362.0M $359.0M
Other Short-Term Assets $482.0M $452.0M $430.0M
YoY Change -62.98% 5.12% 34.38%
Inventory
Prepaid Expenses $670.0M $737.0M $655.0M
Receivables $3.814B $3.296B $2.048B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $21.29B $20.48B $17.63B
YoY Change 10.05% 16.13% 36.95%
LONG-TERM ASSETS
Property, Plant & Equipment $875.0M $805.0M $699.0M
YoY Change -34.7% 15.16% -17.18%
Goodwill $2.800B $2.815B $2.816B
YoY Change -0.74% -0.04% -2.15%
Intangibles $1.498B $1.553B $1.777B
YoY Change -13.01% -12.61% -11.02%
Long-Term Investments $468.0M $443.0M $806.0M
YoY Change 6.36% -45.04% -63.36%
Other Assets $956.0M $973.0M $854.0M
YoY Change 7.9% 13.93% -22.57%
Total Long-Term Assets $7.248B $7.252B $7.574B
YoY Change 0.54% -4.25% -20.35%
TOTAL ASSETS
Total Short-Term Assets $21.29B $20.48B $17.63B
Total Long-Term Assets $7.248B $7.252B $7.574B
Total Assets $28.54B $27.73B $25.21B
YoY Change 7.47% 10.01% 12.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.928B $3.268B $2.132B
YoY Change 85.02% 53.28% 41.76%
Accrued Expenses $3.900B $4.774B $3.584B
YoY Change 12.62% 33.2% 91.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.447B $3.462B $854.0M
YoY Change 303.16% 305.39% -35.93%
Total Short-Term Liabilities $18.21B $16.83B $11.07B
YoY Change 45.87% 52.05% 48.03%
LONG-TERM LIABILITIES
Long-Term Debt $13.36B $13.44B $11.27B
YoY Change 1.24% 19.22% 33.63%
Other Long-Term Liabilities $200.0M $152.0M $172.0M
YoY Change -83.42% -11.63% -15.27%
Total Long-Term Liabilities $13.56B $13.59B $11.44B
YoY Change -5.85% 18.75% 32.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.21B $16.83B $11.07B
Total Long-Term Liabilities $13.56B $13.59B $11.44B
Total Liabilities $32.82B $31.78B $24.13B
YoY Change 20.55% 31.69% 33.98%
SHAREHOLDERS EQUITY
Retained Earnings $33.53B $32.30B $27.81B
YoY Change 15.22% 16.17% 16.92%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $44.96B $43.33B $33.18B
YoY Change 23.79% 30.6% 30.67%
Treasury Stock Shares
Shareholders Equity -$4.276B -$4.052B $1.074B
YoY Change
Total Liabilities & Shareholders Equity $28.54B $27.73B $25.21B
YoY Change 7.47% 10.01% 12.61%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $1.521B $776.0M $266.0M
YoY Change 17.91% 191.73% -138.0%
Depreciation, Depletion And Amortization $142.0M $137.0M $120.0M
YoY Change 17.36% 14.17% 8.11%
Cash From Operating Activities $2.525B $2.704B $2.889B
YoY Change 45.37% -6.4% 70.44%
INVESTING ACTIVITIES
Capital Expenditures $146.0M $130.0M $88.00M
YoY Change 58.7% 47.73% -19.27%
Acquisitions
YoY Change
Other Investing Activities $283.0M $19.00M $9.000M
YoY Change 433.96% 111.11% -175.0%
Cash From Investing Activities $137.0M $69.00M $1.586B
YoY Change -451.28% -95.65% -1410.74%
FINANCING ACTIVITIES
Cash Dividend Paid $299.0M $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $500.0M
YoY Change -100.0% -54.63%
Cash From Financing Activities -1.966B $784.0M -$2.562B
YoY Change 60.49% -130.6% 19.78%
NET CHANGE
Cash From Operating Activities 2.525B $2.704B $2.889B
Cash From Investing Activities 137.0M $69.00M $1.586B
Cash From Financing Activities -1.966B $784.0M -$2.562B
Net Change In Cash 696.0M $3.529B $1.921B
YoY Change 47.15% 83.71% -434.67%
FREE CASH FLOW
Cash From Operating Activities $2.525B $2.704B $2.889B
Capital Expenditures $146.0M $130.0M $88.00M
Free Cash Flow $2.379B $2.574B $2.801B
YoY Change 44.62% -8.1% 76.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Marketing Expense
MarketingExpense
1610000000 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
1517000000 usd
CY2024Q1 bkng Salesandotherexpenses
Salesandotherexpenses
678000000 usd
CY2023Q1 bkng Salesandotherexpenses
Salesandotherexpenses
570000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1074000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
266000000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
113000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
776000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
776000000 usd
CY2024Q1 us-gaap Revenues
Revenues
4415000000 usd
CY2023Q1 us-gaap Revenues
Revenues
3778000000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
144000000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
826000000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
722000000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
186000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
262000000 usd
CY2024Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
187000000 usd
CY2023Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
137000000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
137000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
120000000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
3624000000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3328000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
791000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
450000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
219000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
194000000 usd
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
243000000 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
228000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
122000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-181000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
937000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
303000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
161000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
776000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
266000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
22.69
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.07
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34206000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37621000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
22.37
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.00
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34706000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37983000 shares
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
776000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
266000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-33000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
743000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
266000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2744000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-33000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
6000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
149000000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1904000000 usd
CY2024Q1 us-gaap Dividends
Dividends
302000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-4052000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2782000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
105000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
116000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2195000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
137000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
120000000 usd
CY2024Q1 bkng Provision For Expected Credit Losses And Chargebacks
ProvisionForExpectedCreditLossesAndChargebacks
89000000 usd
CY2023Q1 bkng Provision For Expected Credit Losses And Chargebacks
ProvisionForExpectedCreditLossesAndChargebacks
54000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-35000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-340000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-16000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-133000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
144000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
113000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
40000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
41000000 usd
CY2024Q1 bkng Foreign Currency Transaction Gain Lossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
ForeignCurrencyTransactionGainLossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
167000000 usd
CY2023Q1 bkng Foreign Currency Transaction Gain Lossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
ForeignCurrencyTransactionGainLossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
-26000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
185000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-158000000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
98000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-118000000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
2123000000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
2038000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
136000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-162000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2704000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2889000000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
218000000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1683000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
130000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
19000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
9000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
69000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1586000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2959000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
500000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1856000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2150000000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
299000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
105000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-26000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
784000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2562000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-28000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3529000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1921000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12135000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12251000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15664000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14172000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
164000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
311000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
136000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
142000000 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts from prior periods have been reclassified to conform to the current period presentation. These include the reclassification of certain indirect taxes, primarily digital services taxes, between "General and administrative" expenses and "Sales and other expenses" in the Unaudited Consolidated Statement of Operations. See Notes 2 and 21 to the Consolidated Financial Statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2023.</span></div>
CY2024Q1 us-gaap Revenues
Revenues
4415000000 usd
CY2023Q1 us-gaap Revenues
Revenues
3778000000 usd
CY2024Q1 bkng Sharebased Compensation Arrangementby Sharebased Payment Award Equity Instruments Otherthan Options Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsGrantDateFairValue
594000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
699000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34206000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37621000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
290000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
242000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
210000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
120000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34706000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37983000 shares
CY2024Q1 bkng Short Term Investments Cost
ShortTermInvestmentsCost
363000000 usd
CY2024Q1 bkng Short Term Investments Gross Unrealized Gain
ShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2024Q1 bkng Short Term Investments Gross Unrealized Loss
ShortTermInvestmentsGrossUnrealizedLoss
1000000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
362000000 usd
CY2024Q1 bkng Longterminvestmentcost
Longterminvestmentcost
812000000 usd
CY2024Q1 bkng Longterminvestmentgrossunrealizedgain
Longterminvestmentgrossunrealizedgain
259000000 usd
CY2024Q1 bkng Longterminvestmentgrossunrealizedloss
Longterminvestmentgrossunrealizedloss
628000000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
443000000 usd
CY2023Q4 bkng Short Term Investments Cost
ShortTermInvestmentsCost
580000000 usd
CY2023Q4 bkng Short Term Investments Gross Unrealized Gain
ShortTermInvestmentsGrossUnrealizedGain
0 usd
CY2023Q4 bkng Short Term Investments Gross Unrealized Loss
ShortTermInvestmentsGrossUnrealizedLoss
4000000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
576000000 usd
CY2023Q4 bkng Longterminvestmentcost
Longterminvestmentcost
793000000 usd
CY2023Q4 bkng Longterminvestmentgrossunrealizedgain
Longterminvestmentgrossunrealizedgain
259000000 usd
CY2023Q4 bkng Longterminvestmentgrossunrealizedloss
Longterminvestmentgrossunrealizedloss
612000000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
440000000 usd
CY2024Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-85000000 usd
CY2023Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-17000000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1800000000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1900000000 usd
CY2024Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
1500000000 usd
CY2023Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
1300000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
137000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
117000000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
45000000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
23000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
45000000 usd
CY2024Q1 bkng Accounts Receivable Allowance For Credit Loss Foreign Currency Translation Adjustment Increase Decrease
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustmentIncreaseDecrease
-2000000 usd
CY2023Q1 bkng Accounts Receivable Allowance For Credit Loss Foreign Currency Translation Adjustment Increase Decrease
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslationAdjustmentIncreaseDecrease
1000000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
93000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3529000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1976000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1553000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3544000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1931000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1613000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55000000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2000000000 usd
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
2000000000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
16998000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
16900000000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14249000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
14184000000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
98000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
65000000 usd
CY2024Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
90000 shares
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
315000000 usd
CY2023Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
66000 shares
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
173000000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
536000 shares
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1904000000 usd
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
878000 shares
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2195000000 usd
CY2024Q1 bkng Treasury Stock Repurchased But Unsettled By Period End Amount
TreasuryStockRepurchasedButUnsettledByPeriodEndAmount
47000000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
286000000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
158000000 usd
CY2024Q1 bkng Estimated Excise Tax On Share Repurchases
EstimatedExciseTaxOnShareRepurchases
108000000 usd
CY2023Q4 bkng Estimated Excise Tax On Share Repurchases
EstimatedExciseTaxOnShareRepurchases
96000000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
299000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.171
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.124
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
68000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
67000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
48000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
7000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
7000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-33000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2024Q1 bkng Partner Liability Insurance Maximum
PartnerLiabilityInsuranceMaximum
1000000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
136000000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-53000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-16000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-133000000 usd
CY2024Q1 bkng Other Nonoperating Income Expense Other Miscellaneous Amounts
OtherNonoperatingIncomeExpenseOtherMiscellaneousAmounts
2000000 usd
CY2023Q1 bkng Other Nonoperating Income Expense Other Miscellaneous Amounts
OtherNonoperatingIncomeExpenseOtherMiscellaneousAmounts
5000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
122000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-181000000 usd
CY2024Q1 bkng Foreign Currency Transaction Gain Lossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
ForeignCurrencyTransactionGainLossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
167000000 usd
CY2023Q1 bkng Foreign Currency Transaction Gain Lossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
ForeignCurrencyTransactionGainLossbeforetaxassociatedwiththeremeasurementofnonfunctionalcurrencydebt
-26000000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
16000000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18000000 usd

Files In Submission

Name View Source Status
0001075531-24-000027-index-headers.html Edgar Link pending
0001075531-24-000027-index.html Edgar Link pending
0001075531-24-000027.txt Edgar Link pending
0001075531-24-000027-xbrl.zip Edgar Link pending
bkng-20240331.htm Edgar Link pending
bkng-20240331.xsd Edgar Link pending
bkng-20240331_g1.jpg Edgar Link pending
bkng-20240331_g2.jpg Edgar Link pending
bkng33124ex311.htm Edgar Link pending
bkng33124ex312.htm Edgar Link pending
bkng33124ex321.htm Edgar Link pending
bkng33124ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
bkng-20240331_cal.xml Edgar Link unprocessable
bkng-20240331_def.xml Edgar Link unprocessable
bkng-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bkng-20240331_pre.xml Edgar Link unprocessable
bkng-20240331_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending